Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease

J Parkinsons Dis. 2021;11(4):1475-1489. doi: 10.3233/JPD-212726.

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder, affecting 5%of the elderly population. Currently, the diagnosis of PD is mainly based on clinical features and no definitive diagnostic biomarkers have been identified. The discovery of biomarkers at the earliest stages of PD is of extreme interest. This review focuses on the current findings in the field of circulating non-coding RNAs in PD. We briefly describe the more established circulating biomarkers in PD and provide a more thorough review of non-coding RNAs, in particular microRNAs, long non-coding RNAs and circular RNAs, differentially expressed in PD, highlighting their potential for being considered as biomarkers for diagnosis. Together, these studies hold promise for the use of peripheral biomarkers for the diagnosis of PD.

Keywords: Biomarkers; Parkinson’s disease; circular RNAs; long non-coding RNAs; microRNAs; noncoding RNAs.

Publication types

  • Review

MeSH terms

  • Aged
  • Biomarkers
  • Humans
  • MicroRNAs* / genetics
  • Neurodegenerative Diseases*
  • Parkinson Disease* / diagnosis
  • Parkinson Disease* / genetics
  • RNA, Long Noncoding*

Substances

  • Biomarkers
  • MicroRNAs
  • RNA, Long Noncoding